Evaluation of a new imaging technique to locate, prior to surgery, the lesions producing insulin in excess in patients with endogenous hyperinsulinar hypoglycemia.

Phase 1

• Conditions: MedDRA version: 19.1Level: PTClassification code 10061211Term: HyperinsulinismSystem Organ Class: 10027433 - Metabolism and nutrition disorders; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2015-003317-22-FR
• Lead Sponsor: Centre Hospitalier Régional Universitaire Lille

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-02
• Last Update Posted: 8 January 2018

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 28
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 28

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):